Magnesium in acute myocardial infarction
- 25 March 1995
- Vol. 310 (6982), 751-752
- https://doi.org/10.1136/bmj.310.6982.751
Abstract
Small trials reporting the use of magnesium in acute myocardial infarction have been reported intermittently for 20 years. The rationale for these studies came partly from observations of differences in heart attack rates associated with geographical variations in magnesium in the water supply and partly from laboratory studies showing that magnesium had cardioprotective effects during ischaemia and that myocardial magnesium concentrations were relatively low during acute ischaemia.1Keywords
This publication has 7 references indexed in Scilit:
- Misleading meta-analysisBMJ, 1995
- Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1994
- Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1992
- Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.BMJ, 1991
- Possible pharmacological actions of magnesium in acute myocardial infarction.British Journal of Clinical Pharmacology, 1991
- Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortalityInternational Journal of Cardiology, 1986
- INTRAVENOUS MAGNESIUM IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1986